Biogen (BIIB) stock forecast for 2022. Forecast tables and graphs.

Biogen (BIIB) stock forecast for 2022

The forecast has been updated: August 4, 2021 5:55


Biogen stock price online today

Analyst Target Price

404.41

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

3:1

Last Split Date

18.01.2001

Should you buy or sell Biogen stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Biogen stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $404.41 target price for Biogen stock stock.

Today 200 Day Moving Average is the support level (296.75 $).

50 Day Moving Average is the resistance level (350.34 $).




BIIB Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 294.64 288.14 305.77 5.77 %
Feb 313.51 289.15 338.20 14.50 %
Mar 305.61 286.68 319.73 10.34 %
Apr 309.78 302.95 322.79 6.15 %
May 308.48 290.02 321.76 9.87 %
Jun 321.76 299.80 347.10 13.63 %
Jul 336.96 328.82 360.67 8.83 %
Aug 321.39 300.13 336.58 10.83 %
Sep 307.22 296.25 327.87 9.64 %
Oct 333.03 320.09 344.22 7.01 %
Nov 347.71 319.24 361.22 11.62 %
Dec 353.19 332.42 366.54 9.31 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Biogen stock.


Biogen overview

Biogen Address

225 BINNEY STREET, CAMBRIDGE, MA, US

Market Capitalization

50 262 122 000 $

EBITDA

3 796 300 000

PE Ratio

26.97

PEG Ratio

6.24

Dividend Per Share

None

Dividend Yield

0

EPS

12.5

Quarterly Earnings Growth YOY

-0.688

Quarterly Revenue Growth YOY

-0.246

Trailing PE

26.97

Forward PE

17.54

EV To Revenue

4.554

EV To EBITDA

14.69

52 Week High

427.5

52 Week Low

223.25

50 Day Moving Average

350.34

200 Day Moving Average

296.75

Shares Outstanding

149033000

Shares Float

147987000

Shares Short Prior Month

1924200

Short Ratio

1.01

Percent Insiders

0.679

Percent Institutions

87.3

Biogen stock forecast for this year


Biogen stock forecast for Jan 2022.
Estimated Average Forecasted Biogen Price: 294.64. Negative monthly dynamics of the instrument is expected with 5.767% volatility is expected.

Pessimistic forecast: 288.14

Optimistic: 305.77


Biogen stock forecast for Feb 2022.
Estimated Average Forecasted Biogen Price: 313.51. Positive monthly dynamics of the instrument is expected with 14.503% volatility is expected.

Pessimistic forecast: 289.15

Optimistic: 338.20


Biogen stock forecast for Mar 2022.
Estimated Average Forecasted Biogen Price: 305.61. Negative monthly dynamics of the instrument is expected with 10.337% volatility is expected.

Pessimistic forecast: 286.68

Optimistic: 319.73


Biogen stock forecast for Apr 2022.
Estimated Average Forecasted Biogen Price: 309.78. Positive monthly dynamics of the instrument is expected with 6.147% volatility is expected.

Pessimistic forecast: 302.95

Optimistic: 322.79


Biogen stock forecast for May 2022.
Estimated Average Forecasted Biogen Price: 308.48. Negative monthly dynamics of the instrument is expected with 9.865% volatility is expected.

Pessimistic forecast: 290.02

Optimistic: 321.76


Biogen stock forecast for Jun 2022.
Estimated Average Forecasted Biogen Price: 321.76. Positive monthly dynamics of the instrument is expected with 13.627% volatility is expected.

Pessimistic forecast: 299.80

Optimistic: 347.10


Biogen stock forecast for Jul 2022.
Estimated Average Forecasted Biogen Price: 336.96. Positive monthly dynamics of the instrument is expected with 8.829% volatility is expected.

Pessimistic forecast: 328.82

Optimistic: 360.67


Biogen stock forecast for Aug 2022.
Estimated Average Forecasted Biogen Price: 321.39. Negative monthly dynamics of the instrument is expected with 10.828% volatility is expected.

Pessimistic forecast: 300.13

Optimistic: 336.58


Biogen stock forecast for Sep 2022.
Estimated Average Forecasted Biogen Price: 307.22. Negative monthly dynamics of the instrument is expected with 9.642% volatility is expected.

Pessimistic forecast: 296.25

Optimistic: 327.87


Biogen stock forecast for Oct 2022.
Estimated Average Forecasted Biogen Price: 333.03. Positive monthly dynamics of the instrument is expected with 7.010% volatility is expected.

Pessimistic forecast: 320.09

Optimistic: 344.22


Biogen stock forecast for Nov 2022.
Estimated Average Forecasted Biogen Price: 347.71. Positive monthly dynamics of the instrument is expected with 11.623% volatility is expected.

Pessimistic forecast: 319.24

Optimistic: 361.22


Biogen stock forecast for Dec 2022.
Estimated Average Forecasted Biogen Price: 353.19. Positive monthly dynamics of the instrument is expected with 9.308% volatility is expected.

Pessimistic forecast: 332.42

Optimistic: 366.54



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 121.57 (04.08.2021) -0.45 %
AbbVie Inc.
ABBV 115.08 (04.08.2021) -1.01 %
Aeterna Zentaris Inc.
AEZS 0.7001 (04.08.2021) -1.86 %
Allakos Inc.
ALLK 79.93 (04.08.2021) 2.49 %
Allogene Therapeutics, Inc.
ALLO 22.13 (04.08.2021) 0.91 %
Amgen Inc.
AMGN 228.31 (04.08.2021) -6.46 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 12.4 (04.08.2021) -1.51 %
Aurora Cannabis Inc.
ACB 6.93 (04.08.2021) -3.62 %
Becton Dickinson and Company
BDX 254.74 (04.08.2021) -0.40 %
Biogen Inc.
BIIB 338.1 (04.08.2021) 0.03 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 123.36 (04.08.2021) 3.86 %
BioNTech SE
BNTX 414.44 (04.08.2021) 17.80 %
bluebird bio, Inc.
BLUE 25 (04.08.2021) -0.44 %
Boston Scientific Corp.
BSX 44.26 (04.08.2021) -2.81 %
Bristol-Myers Squibb Company
BMY 68.49 (04.08.2021) -1.18 %
Canopy Growth Corp.
CGC 18.28 (04.08.2021) -2.61 %
Castle Biosciences, Inc.
CSTL 69.19 (04.08.2021) -1.68 %
Eli Lilly and Company
LLY 262.47 (04.08.2021) 2.53 %
Emergent BioSolutions Inc.
EBS 62.04 (04.08.2021) -2.11 %
Exelixis, Inc.
EXEL 16.79 (04.08.2021) -1.06 %
G1 Therapeutics, Inc.
GTHX 16.72 (04.08.2021) -0.59 %
Gilead Sciences, Inc.
GILD 69.24 (04.08.2021) -0.84 %
GlaxoSmithKline plc
GSK 40.5 (04.08.2021) -0.34 %
GoodRx Holdings, Inc.
GDRX 31.78 (04.08.2021) 0.44 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 77.34 (04.08.2021) -0.78 %
Inovio Pharmaceuticals, Inc.
INO 8.76 (04.08.2021) 1.74 %
Johnson & Johnson
JNJ 173.36 (04.08.2021) -0.59 %
Medtronic plc.
MDT 128.38 (04.08.2021) -2.34 %
Merck & Co., Inc.
MRK 75.48 (04.08.2021) -1.22 %
Moderna, Inc.
MRNA 419.05 (04.08.2021) 8.42 %
Novartis AG
NVS 91.59 (04.08.2021) -1.21 %
Novavax, Inc.
NVAX 223.81 (04.08.2021) 18.69 %
ObsEva SA
OBSV 2.49 (04.08.2021) -0.40 %
OrganiGram Holdings Inc.
OGI 2.49 (04.08.2021) -3.49 %
Pfizer Inc.
PFE 45.19 (04.08.2021) -1.07 %
Regeneron Pharmaceuticals, Inc.
REGN 580.95 (04.08.2021) -0.95 %
Sanofi
SNY 49.88 (04.08.2021) -3.15 %
Schrodinger, Inc.
SDGR 68.43 (04.08.2021) 3.06 %
Senseonics Holdings, Inc.
SENS 3.03 (04.08.2021) -1.94 %
Sorrento Therapeutics, Inc.
SRNE 8.23 (04.08.2021) 0.49 %
Stryker Corp.
SYK 262.58 (04.08.2021) -2.03 %
Sundial Growers Inc.
SNDL 0.7811 (04.08.2021) -4.21 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 10 (04.08.2021) 0.81 %
Thermo Fisher Scientific Inc.
TMO 538.88 (04.08.2021) 0.35 %
Tilray, Inc.
TLRY 13.96 (04.08.2021) -2.04 %
UnitedHealth Group, Inc.
UNH 421.54 (04.08.2021) -0.09 %
Veeva Systems Inc.
VEEV 340.98 (04.08.2021) 0.87 %
Zomedica Corp.
ZOM 0.578 (04.08.2021) -4.73 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.33 (04.08.2021) -2.48 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.